Objective To investigate the features of patients with recurrence of hypertriglyceridemic acute pancreatitis( HTG-AP) and the influence of metabolic syndrome( MetS) on recurrence through a retrospective analysis. Methods A retrospective analysis was performed for 132 patients with recurrent HTG-AP who were admitted to The Affiliated Hospital of Southwest Medical University from June 2013 to December( recurrence group),and 132 patients with non-recurrent HTG-AP who were treated during the same period of time were enrolled as control group. Related data were collected,including basic information( age,sex,diabetes,hypertension,and body mass index),clinical data( etiology,routine blood test results,and biochemical results),and complications [systemic inflammatory response syndrome( SIRS),acute peripancreatic fluid collection( APFC),acute necrosis collection( ANC),acute respiratory distress syndrome( ARDS),acute renal failure( ARF),multiple organ dysfunction syndrome( MODS),and ICU admission rate]. The t-test was used for comparison of normally distributed continuous data between groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups.A logistic regression analysis was used for comparison of related variables,and the receiver operating characteristic( ROC) curve was used to validate the diagnostic value of variables. Results Compared with the control group,the recurrence group had a significantly higher proportion of patients with MetS,obesity,a high-density lipoprotein cholesterol( HDL-C) level of < 1 mmol/L,or ANC and significantly higher levels of blood glucose and C-reactive protein( CRP) and white blood cell count( WBC)( χ2= 9. 138,χ2= 6. 823,χ2= 13. 251,χ2=9. 587,Z =-2. 255,Z =-2. 202,Z =-4. 674,all P < 0. 05). The 132 patients in the recurrence group were divided into MetS group with 92 patients and non-Met S group with 40 patients,and compared with the non-Met S group,the Met S group had significantly higher WBC and blood glucose and a significantly higher proportion of patients with SIRS,APFC,ANC,or progression to moderate-to-severe AP( MSAP)( t = 2. 434,t = 4. 881,χ2= 4. 513,χ2= 7. 936,χ2= 7. 031,χ2= 7. 150,all P < 0. 05). Met S( odds ratio [OR]= 2. 007,95%confidence interval [CI]: 1. 152-3. 497,P < 0. 05),ANC( OR = 2. 270,95% CI: 1. 185-4. 347,P < 0. 05),and WBC( OR = 1. 135,95% CI: 1. 059-1. 217,P < 0. 05) were independent risk factors for recurrence in HTG-AP patients. The combination of Met S,ANC,and WBC had a relatively high value in predicting the recurrence of HTG-AP,with an area under the ROC curve of 0. 692. In the recurrence group,the levels of triglyceride,blood glucose,and CRP and the proportion of patients with smoking,HDL-C < 1 mmol/L,or obesity in 125 patients( 7 patients were excluded due to incomplete case data) at the time of recurrence were significantly lower than those in 132 patients at initial admission( Z =-3. 270,Z =-3. 546,Z =-4. 382,χ2= 0547,χ2= 8. 259,χ2= 5. 143,all P < 0. 05),with further reductions in the proportion of patients with MSAP,APFC,or ANC( χ2= 4. 086,χ2= 11. 930,χ2= 4. 967,all P < 0. 05).Conclusion Met S aggravates disease severity in patients with recurrent HTG-AP and is an important factor for recurrence. Smoking cessation,weight loss,and oral lipid-lowering drugs can reduce disease severity at the time of readmission.
[1] Pancreas Study Group,Chinese Society of Gastroenterology,Chinese Medical Association; Editorial Board of Chinese Journal of Pancreatology,Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis(Shenyang,2019)[J]. J Clin Hepatol,2019,35(12):2706-2711.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].临床肝胆病杂志,2019,35(12):2706-2711.
|
[2] FORSMARK CE,VEGE SS,WILCOX CM. Acute pancreatitis[J]. N Engl J Med,2016,375(20):1972-1981.
|
[3] GARG SK,SARVEPALLI S,CAMPBELL JP,et al. Incidence,admission rates,and predictors,and economic burden of adult emergency visits for acute pancreatitis:Data from the national emergency department sample,2006 to 2012[J]. J Clin Gastroenterol,2019,53(3):220-225.
|
[4] ZHOU MT,SHI KQ,TIAN X,et al. Clinical classification and treatment of hyperlipidemic acute pancreatitis[J]. J Hepatopancreatobiliary Surg,2019,31(1):19-20.(in Chinese)周蒙滔,施可庆,田新,等.高脂血症性急性胰腺炎的临床分型及救治方案[J].肝胆胰外科杂志,2019,31(1):19-20.
|
[5] SEPPANEN H,PUOLAKKAINEN P. Classification,severity assessment,and prevention of recurrences in acute pancreatitis[J]. Scand J Surg,2020,109(1):53-58.
|
[6] CHO JH,JEONG YH,KIM KH,et al. Risk factors of recurrent pancreatitis after first acute pancreatitis attack:A retrospective cohort study[J]. Scand J Gastroenterol,2020,55(1):90-94.
|
[7] MIKOLASEVIC I,MILIC S,ORLIC L,et al. Metabolic syndrome and acute pancreatitis[J]. Eur J Intern Med,2016,32:79-83.
|
[8] DOUBILET H,MULHOLLAND JH. Recurrent acute pancreatitis,observations on etiology and surgical treatment[J]. Ann Surg,1948,128(4):609-638.
|
[9] ZHANG FS,MA HY,ZOU DP. Analysis of clinical features and causes of acute recurrent pancreatitis[J]. Mod Med J China,2019,21(8):81-83.(in Chinese)张佛生,马海云,邹大朋.急性复发性胰腺炎的临床特点和病因分析[J].中国现代医药杂志,2019,21(8):81-83.
|
[10] AHMED ALI U,ISSA Y,HAGENAARS JC,et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis[J]. Clin Gastroenterol Hepatol,2016,14(5):738-746.
|
[11] MAGNUSDOTTIR BA,BALDURSDOTTIR MB,KALAITZAKIS E,et al. Risk factors for chronic and recurrent pancreatitis after first attack of acute pancreatitis[J]. Scand J Gastroenterol,2019,54(1):87-94.
|
[12] XIANG JX,HU LS,LIU P,et al. Impact of cigarette smoking on recurrence of hyperlipidemic acute pancreatitis[J]. World J Gastroenterol,2017,23(47):8387-8394.
|
[13] PANG Y,KARTSONAKI C,TURNBULL I,et al. Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults:A prospective cohort study of 0. 5 million people[J]. PLo S Med,2018,15(8):e1002618.
|
[14] McCRACKEN E,MONAGHAN M,SREENIVASAN S. Pathophysiology of the metabolic syndrome[J]. Clin Dermatol,2018,36(1):14-20.
|
[15] LI X,GUO X,JI H,et al. Relationships between metabolic comorbidities and occurrence,severity,and outcomes in patients with acute pancreatitis:A narrative review[J]. Biomed Res Int,2019,2019:2645926.
|
[16] SZENTESI A,PARNICZKY A,VINCZEA,et al. Multiple hits in acute pancreatitis:Components of metabolic syndrome synergize each other’s deteriorating effects[J]. Front Physiol,2019,10:1202.
|
[17] HUANG Y,WANG Y. Clinical analysis of diabetes mel itus complicated with hyperlipidemic acute pancreatitis[J]. Chin J Gastroenterol,2018,23(7):423-425.(in Chinese)黄瑶,王营.糖尿病合并高脂血症性急性胰腺炎的临床分析[J].胃肠病学,2018,23(7):423-425.
|
[18] NIU L,GE LC. Acute recurrent pancreatitis and hyperlipidemia:Reciprocal causal relationship and clinical features[J]. World Chin J Dig,2016,24(30):4205-4210.(in Chinese)牛蕾,葛林春.急性复发性胰腺炎与高脂血症的互为因果关系及临床特点[J].世界华人消化杂志,2016,24(30):4205-4210.
|
[19] NIKNAM R,MORADI J,JAHANSHAHI KA,et al. Association between metabolic syndrome and its components with severity of acute pancreatitis[J]. Diabetes Metab Syndr Obes,2020,13:1289-1296.
|
[20] KISS L,FUR G,MATRAI P,et al. The effect of serum triglyceride concentration on the outcome of acute pancreatitis:systematic review and meta-analysis[J]. Sci Rep,2018,8(1):14096.
|
[21] MIKOA,FARKAS N,GARAMI A,et al. Preexisting diabetes elevates risk of local and systemic complications in acute pancreatitis:Systematic review and meta-analysis[J]. Pancreas,2018,47(8):917-923.
|
[22] CATANZARO R,CUFFARI B,ITALIA A,et al. Exploring the metabolic syndrome:Nonalcoholic fatty pancreas disease[J]. World J Gastroenterol,2016,22(34):7660-7675.
|
[23] ALEMPIJEVIC T,DRAGASEVIC S,ZEC S,et al. Non-alcoholic fatty pancreas disease[J]. Postgrad Med J,2017,93(1098):226-230.
|
[24] PATEL K,TRIVEDI RN,DURGAMPUDI C,et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation[J]. Am J Pathol,2015,185(3):808-819.
|
[25] JIANG XL,YANG F,WANG CH,et al. Correlation between serum level of cytokine and disease severity in HALP patients[J]. Med J West China,2017,29(4):489-493,498.(in Chinese)蒋晓岚,杨帆,王春晖,等.高脂血症性急性胰腺炎血清细胞因子水平与病情严重程度的相关性[J].西部医学,2017,29(4):489-493,498.
|
[26] BAIG S,SHABEER M,PARVARESH RIZI E,et al. Heredity of type 2 diabetes confers increased susceptibility to oxidative stress and inflammation[J]. BMJ Open Diabetes Res Care,2020,8(1):e000945.
|
[27] KEBKALO A,TKACHUK O,REYTI A. Features of the course of acute pancreatitis in patients with obesity[J]. Pol Przegl Chir,2019,91(6):28-34.
|
[28] SHARMA D,JAKKAMPUDI A,REDDY R,et al. Association of systemic inflammatory and anti-inflammatory responses with adverse outcomes in acute pancreatitis:Preliminary results of an ongoing study[J]. Dig Dis Sci,2017,62(12):3468-3478.
|
[29] RUIZ-REBOLLO ML,MUNOZ-MORENO MF,MAYOISCAR A,et al. Statin intake can decrease acute pancreatitis severit[J]. Pancreatology,2019,19(6):807-812.
|
1. | 朱成诚,丁世兰. 超声剪切波弹性成像对肝纤维化的临床应用进展. 现代医药卫生. 2022(22): 3874-3879+3883 . ![]() | |
2. | 肖毅,秦建伟. 肝硬化患者门静脉压力、脾静脉血流参数与SWE结果的特征分析. 甘肃科技. 2020(12): 101-104 . ![]() | |
3. | 董丙田,黄枢. 超声弹性成像在肝脏疾病的临床应用. 医学综述. 2019(05): 1002-1006 . ![]() | |
4. | 刘旭. 门静脉右支前间隙行磁共振改良测量对肝纤维化和肝硬化的诊断效果. 肝脏. 2019(05): 541-544 . ![]() | |
5. | 杨淑丽,诸绍锋,张蕾,石鹏,王姜莹,傅佳. 超声实时组织弹性成像定量分析对肝脏纤维化程度的诊断和鉴别诊断价值. 中国临床保健杂志. 2019(04): 526-529 . ![]() | |
6. | 林培艺. 无创性肝纤维化检测对肝硬化严重程度的评估作用. 慢性病学杂志. 2019(07): 1109-1110+1113 . ![]() | |
7. | 秦敏. 术前瞬时弹性超声检查对肝内结石肝切除术安全性的影响. 肝脏. 2019(08): 935-938 . ![]() | |
8. | 许琴,贡雪灏,郭国强. 实时剪切波弹性成像对慢性乙型肝炎患者早期肝纤维化的诊断价值. 临床和实验医学杂志. 2019(20): 2225-2227 . ![]() | |
9. | 孟艳,隆仙琴,李杰,丁文波. RTE与VTI对肝脏局灶良恶性病变的诊断. 中国临床研究. 2018(02): 255-258 . ![]() | |
10. | 杨皖东,肖春华,陈晓,普慧敏. 弹性成像技术对肝移植供体评估的研究进展. 中国当代医药. 2018(03): 18-20 . ![]() | |
11. | 徐列明. 中医药抗肝纤维化疗效评价的探索. 临床肝胆病杂志. 2017(05): 825-828 . ![]() | |
12. | 梁健,钟碧莹,汤茵,肖秀金,叶红. 肝纤维化检测在非酒精性脂肪肝诊断中的应用研究. 中国卫生标准管理. 2017(17): 110-113 . ![]() |